[Long-term results of adjuvant endocrine therapy for hormone receptor-positive breast cancer]

Vopr Onkol. 2011;57(5):567-77.

[Article in Russian]

Authors

V F Semilgazov, A G Manikhas, V V Semiglazov, A A Bozhok, G A Dashian, V G Ivanov, R M Paltuev, A G Vasil'ev, D E Shchedrin, A M Ermachenkova, I V Nikitina, K D Pen'kov, A A Bessonov, T T Tabagua, V V Kolar'kova

PMID: 22238925

No abstract available

Publication types

Review

MeSH terms

Antineoplastic Agents, Hormonal / therapeutic use*
Aromatase Inhibitors / therapeutic use
Biomarkers, Tumor / analysis*
Breast Neoplasms / chemistry
Breast Neoplasms / drug therapy*
Chemotherapy, Adjuvant
Drug Administration Schedule
Female
Humans
Neoplasms, Hormone-Dependent / chemistry
Neoplasms, Hormone-Dependent / drug therapy*
Premenopause
Receptors, Estrogen / analysis*
Receptors, Progesterone / analysis*
Tamoxifen / therapeutic use
Treatment Outcome

Substances

Antineoplastic Agents, Hormonal
Aromatase Inhibitors
Biomarkers, Tumor
Receptors, Estrogen
Receptors, Progesterone
Tamoxifen